Position history for CAPITAL FUND MANAGEMENT S.A.'s holdings in CRISPR THERAPEUTICS AG
CAPITAL FUND MANAGEMENT S.A. previously held 0 shares of CRSP (CRISPR THERAPEUTICS AG), worth $0 as of 2025-Q1.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Other major holders of CRSP: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Exited |
| 0 |
-100.0% |
| $0 |
| 0.0% |
| $36.99 |
0 |
| 2024-Q4 | Decreased | 18,097 | -63.9% | $712,297 | 0.0% | $38.65 | 0 |
| 2024-Q3 | New | 50,104 | - | $2.4M | 0.0% | $47.32 | 36 |
| 2024-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $54.01 | 0 |